Incyte Corporation INCY
117.59 USD -2.45 (-2.04%)
At closeNov 3, 2026, 4:42 PM EST
117.59 0.00 0.00%
After hours · Nov 3, 4:42 PM ET
117.27 Day range 121.05
89.25 52-week range 132.60
- YTD
- +19.05%
- 1 year
- +15.77%
Analyst view
Consensus: buy
Buy
Price target (mean) 131.08 +11.5% upside
Now 117.59
- Target (low)
- 86.00
- Target (mean)
- 131.08
- Target (high)
- 157.00
Ratings (0m) 28 13 buy · 14 hold · 1 sell
- Strong buy2
- Buy11
- Hold14
- Sell1
- Strong sell0
Recommendation trend
- This month 28
- 1 month ago 28
- 2 months ago 28
- 3 months ago 28
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 1.98 | 1.59 – 3.08 | 1.80 | +10.0% | 1.55B | +3.1% | 17 |
| Next quarter | 1.75 | 1.15 – 1.95 | 1.81 | -3.4% | 1.36B | +7.2% | 6 |
| Current year | 3.46 | 2.76 – 4.38 | 6.80 | -49.2% | 6.03B | +17.3% | 18 |
| Next year | 8.66 | 6.19 – 9.95 | 3.46 | +150.6% | 6.31B | +4.6% | 21 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Bernstein | Maintained | Market Perform | Market Perform |
| Oct 30, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 30, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 30, 2026 | Barclays | Maintained | Overweight | Overweight |
| Oct 30, 2026 | Evercore ISI Group | Maintained | In-Line | In-Line |
| Oct 30, 2026 | Oppenheimer | Upgrade | Perform | Outperform |
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 14, 2026 | Truist Securities | Maintained | Hold | Hold |
| Oct 13, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Oct 5, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 1, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Sep 28, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Sep 22, 2026 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Aug 20, 2026 | Canaccord Genuity | Initiated | — | Buy |
| Aug 20, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 17, 2026 | Piper Sandler | Maintained | Overweight | Overweight |
| Aug 4, 2026 | Mizuho | Maintained | Outperform | Outperform |
| Aug 3, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 3, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 29, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 29, 2026 | BMO Capital | Maintained | Market Perform | Market Perform |
| Jul 29, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jul 29, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 23, 2026 | JP Morgan | Maintained | Neutral | Neutral |
| Jul 23, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 21, 2026 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 14, 2026 | Barclays | Maintained | Overweight | Overweight |
